Increased COVID-19 Mortality and Deficient SARS-CoV-2 Immune Response Are Not Associated with Higher Levels of Endemic Coronavirus Antibodies

被引:2
|
作者
Adhikari, Bindu [1 ,2 ]
Oltz, Eugene M. [3 ]
Bednash, Joseph S. [4 ]
Horowitz, Jeffrey C. [4 ]
Amimo, Joshua O. [2 ]
Raev, Sergei A. [2 ]
Fernandez, Soledad [5 ,6 ]
Anghelina, Mirela [5 ,6 ]
Liu, Shan-Lu [3 ,7 ,8 ,9 ]
Rubinstein, Mark P. [10 ,11 ]
Jones, Daniel M. [12 ]
Saif, Linda J. [1 ,2 ]
Vlasova, Anastasia N. [1 ,2 ]
机构
[1] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Wooster, OH 44691 USA
[2] Ohio State Univ, Coll Food Agr & Environm Sci, Ctr Food Anim Hlth, Dept Anim Sci,OARDC, Wooster, OH 44691 USA
[3] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA
[4] Ohio State Univ, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA
[5] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA
[6] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA
[7] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA
[8] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA
[9] Ohio State Univ, Infect Dis Inst, Viruses & Emerging Pathogens Program, Columbus, OH 43210 USA
[10] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[11] Ohio State Univ, Pelotonia Inst Immunooncol, James Comprehens Canc Ctr, Columbus, OH 43210 USA
[12] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA
来源
IMMUNO | 2023年 / 3卷 / 03期
关键词
SARS-CoV-2; common cold coronavirus; serological testing; immunocompromised patients; antibodies;
D O I
10.3390/immuno3030020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The impact of pre-existing common cold coronavirus (CCCoV) antibodies (Abs) on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and pathogenesis remains poorly defined. We evaluated these associations in a cohort of hospitalized patients with COVID-19 and respiratory failure of varying severity. Patients with respiratory failure from other causes (non-COVID-19) were evaluated as controls. We demonstrated a positive correlation between levels of CCCoV and SARS-CoV-2 Abs using CCCoV and SARS-CoV-2 N and S protein peptide-specific ELISA. Consistent with the above, moderately increased levels of CCCoV-specific Abs in non-COVID-19 vs. COVID-19 patients suggest potential protective effects. Further, higher SARS-CoV-2 N protein-specific and CCCoV Ab levels were observed among surviving vs. non-surviving COVID-19 positive patients. However, the highest SARS-CoV-2 N and S protein-specific IgG and IgA Ab levels were noted in the patients with the most severe clinical disease. Finally, advanced age, cancer and immunosuppression were associated with significantly higher mortality and reduced SARS-CoV-2 and CCCoV Ab levels. Thus, our data highlight that sufficient SARS-CoV-2 N protein-specific Ab responses improve clinical outcomes in severely ill COVID-19 patients. We also confirmed that pre-existing CCCoV-specific Abs do not inhibit the SARS-CoV-2 Ab response and may further reduce the prevalence and/or severity of COVID-19.
引用
收藏
页码:330 / 345
页数:16
相关论文
共 50 条
  • [1] A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia
    Pita-Martinez, Carlos
    Perez-Garcia, Felipe
    Berdices, Ana Virseda
    Martin-Vicente, Maria
    Castilla-Garcia, Lucia
    Fernandez, Irene Hervas
    Ventosa, Victoria Gonzalez
    Munoz-Gomez, Maria Jose
    Cuadros-Gonzalez, Juan
    Bermejo-Martin, Jesus F.
    Resino, Salvador
    Martinez, Isidoro
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 134 : 126 - 132
  • [2] Coronavirus, COVID-19 and SARS-CoV-2
    Megias, Jorge
    REVISTA HISPANOAMERICANA DE HERNIA, 2020, 8 (02) : 111 - 111
  • [3] VIEWPOINT: COVID-19 Will SARS-CoV-2 become endemic?
    Shaman, Jeffrey
    Galanti, Marta
    SCIENCE, 2020, 370 (6516) : 527 - +
  • [4] Rehabilitation with coronavirus disease with SARS-CoV-2 (COVID-19)
    Platz, Thomas
    Dewey, Stefan
    Koellner, Volker
    Schlitt, Axel
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (15) : 981 - 988
  • [5] Rehabilitation with coronavirus disease with SARS-CoV-2 (COVID-19)
    Platz, Thomas
    Dewey, Stefan
    Koellner, Volker
    Schlitt, Axel
    REHABILITATION, 2022, 61 (04) : 297 - 310
  • [6] COVID-19, coronavirus, SARS-CoV-2 and the small bowel
    Moenkemueller, Klaus
    Fry, Lucia C.
    Rickes, Steffen
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (05) : 383 - 388
  • [7] Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
    Li, Xianghui
    Zhang, Yabo
    He, Libing
    Si, Jiangzhe
    Qiu, Shuai
    He, Yuhua
    Wei, Jiacun
    Wang, Zhili
    Xie, Longxiang
    Li, Yanzhang
    Teng, Tieshan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (05): : 1865 - 1877
  • [8] SARS-CoV-2 genomic variations associated with mortality rate of COVID-19
    Toyoshima, Yujiro
    Nemoto, Kensaku
    Matsumoto, Saki
    Nakamura, Yusuke
    Kiyotani, Kazuma
    JOURNAL OF HUMAN GENETICS, 2020, 65 (12) : 1075 - 1082
  • [9] Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19
    Nakamichi, Kenji
    Shen, Jolie Z.
    Lee, Cecilia S.
    Lee, Aaron
    Roberts, Emma A.
    Simonson, Paul D.
    Roychoudhury, Pavitra
    Andriesen, Jessica
    Randhawa, April K.
    Mathias, Patrick C.
    Greninger, Alex L.
    Jerome, Keith R.
    Van Gelder, Russell N.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] SARS-CoV-2 genomic variations associated with mortality rate of COVID-19
    Yujiro Toyoshima
    Kensaku Nemoto
    Saki Matsumoto
    Yusuke Nakamura
    Kazuma Kiyotani
    Journal of Human Genetics, 2020, 65 : 1075 - 1082